Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Import Bill Prohibits Contracts To Prevent Return Shipments To U.S.

Executive Summary

Drug manufacturers would not be able to use contracts with foreign distributors to prohibit reimportation of their products under the version of the prescription drug import amendments approved by the Agriculture Appropriations conference Oct. 5.

You may also be interested in...



Reimportation

Agriculture Appropriations Conference Report passes the House Oct. 11 by a vote of 340 to 75. The report includes language that would allow the reimportation of prescription drugs (1"The Pink Sheet" Oct. 9, p. 7). The Senate began debating the measure Oct. 13 and will vote on the report Oct. 18

Reimportation

Agriculture Appropriations Conference Report passes the House Oct. 11 by a vote of 340 to 75. The report includes language that would allow the reimportation of prescription drugs (1"The Pink Sheet" Oct. 9, p. 7). The Senate began debating the measure Oct. 13 and will vote on the report Oct. 18

SNP Consortium's Next Focus Could Be Drug Safety, Bristol Exec Suggests

The pharmaceutical industry SNP consortium's next focus should be on data that could help minimize side effects, Bristol-Myers Squibb Senior VP-Early Discovery & Applied Technology Elliot Sigal, MD/PhD, suggested.

Related Content

UsernamePublicRestriction

Register

OM013214

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel